Search results :

Insulin

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: A10AB01, A10AB02, A10AB03, A10AC01, A10AC02, A10AC03, A10AD01, A10AD02, A10AD03, A10AE01, A10AE02, A10AE03, A10AF01

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Respiratory tract infection 19.7% - 43.3% x
Cough 4.9% - 29.4% 5.4% - 19.7% x x x
Cough increased 3.7% - 29.5% x
Nasopharyngitis 0.211% - 12.9% x x
Rhinitis 3% - 14.5% x
Upper respiratory tract infection 0.337% - 10.8% x x
Hypoglycaemia very common, 0.296% - 67% 1.7% - 30% x x x x x x x x x x x x x x
Hypoglycaemic seizure 4.7% - 6.1% x x
Swelling common x x x x x x x x
Injection site reaction common x x x x x x x x
Redness common x x x x x x x
Hypertension 3.9% - 5.3% x
Throat sore 1.9% - 5.5% 0.9% - 3.8% x
Arthralgia 0.921% - 6.3% x x
Influenza 0.689% - 6.2% x x
Headache 0.468% - 11.2% 1.8% - 2.8% x x x x x x x
Sinusitis 0.157% - 10.3% x x
Oedema peripheral 0.905% - 7.8% x x x x x
Pharyngitis 0.2% - 18.2% x x x
Hypersensitivity uncommon, common x x x x x x x x x x x x x x x
Pruritus uncommon, common x x x x x x x x x x
Diarrhoea 0.402% - 3.18% 1.4% - 2.2% x x x
Back pain 0.459% - 3.05% x
Dyspnoea uncommon, 1.4% - 4.4% x x x x x x x x
Bronchitis 1% - 5.4% x x x
Urinary tract infection 1% - 2.3% x x
Productive cough 2.2% 0.9% - 1% x x
Fatigue 2% 0.6% - 0.7% x x x x x x
Hypoglycaemic coma 0.232% - 2.74% x x
Vomiting 1% - 2.02% x x
Nausea 0.481% - 2.31% 0.3% - 1% x x x x x x
Pulmonary function test decreased 1% - 2.8% x
Sputum increased 0.1% - 3.9% x
Asthma 0.5% - 2% x
Epistaxis 0.8% - 1.3% x x
Pneumonia 0.6% - 0.9% x
Dermatitis atopic uncommon x x
Urticaria uncommon x x x x
Chest tightness uncommon x x
Laryngitis 0.3% - 1.1% x
Obstruction 0.08% - 0.15% x x
Lipodystrophy rare x x x x x x x x x x x x
Anaphylactic shock x x x x x x
Angina pectoris x x
Angioedema x x x x x
Anxiety x x x x x
Asthenia x x x x x
Bronchospasm x x x x
Cellulitis x
Chest pain x x
Infection x x
Confusional state x x x x
Diabetic ketoacidosis x x x
Diabetic retinopathy x x
Dizziness x
Drowsiness x x x x x
Ear disorder x
Ear pain x
Oedema x x x x x x x
Rash x x x x x
Eye disorder x x x x
Gastrointestinal disorder x x
Glycosuria x x x
Cardiac failure x
Haemorrhage x
Hunger x x x x x
Hypernatraemia x x x x x
Hypokalaemia x x x
Hypotension x x x x
Immune system disorder x x x x
Irritability x x
Lung disorder x
Mediastinal disorder x
Myocardial infarction x x
Nervous system disorder x x
Nervousness x x x x
Nodule x
Otitis media x
Pain x x
Palpitations x x x x x x
Paraesthesia x
Neuropathy peripheral x x x
Pleural effusion x
Refraction disorder x x
Retinal disorder x x x x x
Convulsion x x x x x x x
Serum sickness x
Shock x x x
Sleep disturbance x
Sweating x x x x x
Syncope x
Tachycardia x x x x
Thirst x
Tremor x x x x x
Loss of consciousness x x x x x x x
Erythema x x
Pollakiuria x
Weight increased x x x x
Weight decreased x
Wheezing x x x x
Dry mouth x x x
Agitation x
Mood swings x
Cough decreased x x
Injection site swelling x x
Injection site inflammation x x
Injection site mass x
Injection site pain x x
Dry skin x
Malnutrition x x x x x x x x
Unspecified disorder of skin and subcutaneous tissue x x x x x x x
Lightheadedness x x
Myalgia x x
Cold sweat x x x x
Disorientation x
Abnormal behaviour x
Slurred speech x
Cerebration impaired x x x x x
Dry throat x
Breath odour ketones x
Swollen tongue x
Personality change x
Pallor of skin x x x x
Diabetic autonomic neuropathy x
Tonsillar disorder x
Retinopathy proliferative x x
Neuroglycopenia x x
Vision blurred x
Depressed mood x
Injection site urticaria x x
Warmth x
Neuropathy x
Rash generalised x x
Injection site haematoma x x
Carcinoma of lung x
Throat irritation x
Sweating increased x
Hypoglycaemic episode x
Infestation NOS x x
Heart failure signs and symptoms x
Injection site erythema x x
Injection site pruritus x x
Local swelling x
Local reaction x
Injection site hypertrophy x
Worsening of diabetes x x x x
Pharyngolaryngeal pain x
Potassium low x
Lipodystrophy acquired x
Injection site stinging x
Lipohypertrophy x x x x
Lipoatrophy x x x x
Dysphonia x
Systemic allergic reaction x
Coronary artery disease x x
Appetite absent x
Tingling sensation x
Infusion site reactions x x
Gastrointestinal tract irritation x x
Visual impairment x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

INSULIN HUMAN

Side effects:22
Source:FDA Structured Product Label

insulin human

Side effects:23
Source:FDA Structured Product Label

insulin human / insulin human

Side effects:31
Source:EMA

insulin human / insulin human

Side effects:26
Source:EMA

insulin human / insulin human

Side effects:26
Source:EMA

INSULIN HUMAN

Side effects:18
Source:FDA Structured Product Label

insulin glulisine

Side effects:36
Source:FDA Structured Product Label

Insulin human

Side effects:42
Source:FDA Structured Product Label

insulin human (rDNA) / insulin human

Side effects:29
Source:EMA

insulin human (rDNA) / insulin human

Side effects:37
Source:EMA

insulin degludec / insulin degludec

Side effects:38
Source:EMA

insulin glulisine / insulin glulisine

Side effects:31
Source:EMA

Insulin glulisine / APIDRA

Side effects:43
Source:medicines.org.au

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label